UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease

Gut, 2010-08, Vol.59 (8), p.1079-1087

2010

Volltextzugriff (PDF)

Adoptive T‐Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy

American journal of transplantation, 2009-07, Vol.9 (7), p.1679-1684

2009

Volltextzugriff (PDF)

Validation of leukapheresis procedure and extended release testing for manufacturing of ATMPs

Cytotherapy (Oxford, England), 2017-05, Vol.19 (5), p.S83-S84

2017

Volltextzugriff (PDF)

Extended Product Release Testing in Stem Cell Transplantation and Cellular Immunotherapy of Patients with Multiple Myeloma. Development of Highly Standardized and Sensitive Detection of Malignant Plasma Cells in Autologous Cell Products and Peripheral Blood of Myeloma Patients by Flow Cytometry

Cytotherapy (Oxford, England), 2016-06, Vol.18 (6), p.S11-S12

2016

Volltextzugriff (PDF)

Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection

Medical microbiology and immunology, 2014-04, Vol.203 (2), p.115-123

2014

Volltextzugriff (PDF)

Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines

Medical microbiology and immunology, 2012-08, Vol.201 (3), p.277-286

2012

Volltextzugriff (PDF)

In vivo diagnosis of acute intestinal graft-versus-host disease by confocal endomicroscopy

Endoscopy, 2009-05, Vol.41 (5), p.433-438

2009

Volltextzugriff (PDF)

Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients

International journal of hematology, 2007-08, Vol.86 (2), p.158-162

2007

Volltextzugriff (PDF)

Reply to Dr Grzywacz

Leukemia, 2007-02, Vol.21 (2), p.359-359

2007

Volltextzugriff (PDF)

P-210 Azacitidine and DLI as salvage therapy for MDS or AML relapse after allo-SCT induces long-term molecular remissions and increases Tregs

Leukemia research, 2013-05, Vol.37, p.S118-S118

2013

Volltextzugriff (PDF)

Chimäre antigenspezifische T-Lymphozyten und natürliche Killerzellen für die Krebsimmuntherapie

Transfusionsmedizin - Immunhämatologie, Hämotherapie, Immungenetik, Zelltherapie, 2016-08, Vol.6 (3), p.130-141

2016

Volltextzugriff (PDF)

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD

Blood, 2006-02, Vol.107 (4), p.1717-1723

2006

Volltextzugriff (PDF)

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Blood, 2010-08, Vol.116 (6), p.971-978

2010

Volltextzugriff (PDF)

Rabbit antithymocyte globulin (Thymoglobulin®) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients

Haematologica (Roma), 2013-01, Vol.98 (1), p.23-30

2013

Volltextzugriff (PDF)

Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo

Haematologica (Roma), 2009-06, Vol.94 (6), p.857-860

2009

Volltextzugriff (PDF)

129 - Validation of leukapheresis procedure and extended release testing for manufacturing of ATMPs

Cytotherapy (Oxford, England), 2017-05, Vol.19 (5), p.S83-S84

2017

Volltextzugriff (PDF)

15 - Extended Product Release Testing in Stem Cell Transplantation and Cellular Immunotherapy of Patients with Multiple Myeloma. Development of Highly Standardized and Sensitive Detection of Malignant Plasma Cells in Autologous Cell Products and Peripheral Blood of Myeloma Patients by Flow Cytometry

Cytotherapy (Oxford, England), 2016-06, Vol.18 (6), p.S11-S12

2016

Volltextzugriff (PDF)

Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice

British journal of haematology, 1997-03, Vol.96 (4), p.757-761

1997

Volltextzugriff (PDF)

Therapeutic spectrum in the treatment of myelodysplastic syndromes

Expert opinion on pharmacotherapy, 2004-12, Vol.5 (12), p.2451-2458

2004

Volltextzugriff (PDF)

Efficacy of the interleukin‐2 receptor antagonist basiliximab in steroid‐refractory acute graft‐versus‐host disease

British journal of haematology, 2005-08, Vol.130 (4), p.568-574

2005

Volltextzugriff (PDF)

Zelltherapie bei CED: Vergleich von mesenchymale Stammzellen und regulatorischen T-Zellen in präklinischen murinen Modellen

Zeitschrift für Gastroenterologie, 2010, Vol.48 (8)

2010

Volltextzugriff (PDF)

Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells

Blood, 2000-07, Vol.96 (2), p.594-600

2000

Volltextzugriff (PDF)

Activation of natural killer cells with interleukin 2 (IL‐2) and IL‐12 increases perforin binding and subsequent lysis of tumour cells

British journal of haematology, 2001-09, Vol.114 (3), p.660-665

2001

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan

Leukemia & lymphoma, 2006, Vol.47 (1), p.59-63

2006

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation following conditioning with 90 Y-ibritumomab-tiuxetan

Leukemia & lymphoma, 2006-01, Vol.47 (1), p.59-63

2006

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(82)
Deutsch
(8)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease

Adoptive T‐Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy

Validation of leukapheresis procedure and extended release testing for manufacturing of ATMPs

Extended Product Release Testing in Stem Cell Transplantation and Cellular Immunotherapy of Patients with Multiple Myeloma. Development of Highly Standardized and Sensitive Detection of Malignant Plasma Cells in Autologous Cell Products and Peripheral Blood of Myeloma Patients by Flow Cytometry

Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection

Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines

In vivo diagnosis of acute intestinal graft-versus-host disease by confocal endomicroscopy

Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients

Reply to Dr Grzywacz

P-210 Azacitidine and DLI as salvage therapy for MDS or AML relapse after allo-SCT induces long-term molecular remissions and increases Tregs

Chimäre antigenspezifische T-Lymphozyten und natürliche Killerzellen für die Krebsimmuntherapie

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Rabbit antithymocyte globulin (Thymoglobulin®) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients

Angiotensin-(1-7) stimulates hematopoietic progenitor cells in vitro and in vivo

129 - Validation of leukapheresis procedure and extended release testing for manufacturing of ATMPs

15 - Extended Product Release Testing in Stem Cell Transplantation and Cellular Immunotherapy of Patients with Multiple Myeloma. Development of Highly Standardized and Sensitive Detection of Malignant Plasma Cells in Autologous Cell Products and Peripheral Blood of Myeloma Patients by Flow Cytometry

Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice

Therapeutic spectrum in the treatment of myelodysplastic syndromes

Efficacy of the interleukin‐2 receptor antagonist basiliximab in steroid‐refractory acute graft‐versus‐host disease

Zelltherapie bei CED: Vergleich von mesenchymale Stammzellen und regulatorischen T-Zellen in präklinischen murinen Modellen

Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells

Activation of natural killer cells with interleukin 2 (IL‐2) and IL‐12 increases perforin binding and subsequent lysis of tumour cells

Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan

Allogeneic hematopoietic cell transplantation following conditioning with 90 Y-ibritumomab-tiuxetan

Aktive Filter

Suchergebnisse filtern